{
    "nctId": "NCT04374825",
    "briefTitle": "Optimizing Quality of Life in Women Living With Metastatic Breast Cancer",
    "officialTitle": "Optimizing Quality of Life in Women Living With Metastatic Breast Cancer: Feasibility and Preliminary Efficacy of a Tailored, eHealth Supportive Oncology Intervention",
    "overallStatus": "COMPLETED",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 31,
    "primaryOutcomeMeasure": "Change in health-related quality of life (HRQoL)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients must be diagnosed with metastatic (stage IV \\[M1\\]) female breast cancer, via physician diagnosis and confirmed through staff review of electronic medical record (i.e. imaging, surgical pathology reports, etc.).\n* Patients must be comfortable speaking English for participation in group sessions.\n* Patients must be age \u2265 18 years.\n* Patients taking part in the 8 week online pilot trial must have a physician-anticipated life expectancy of \\> 6 months.\n* Patients must have the ability to understand, and the willingness to sign, a written informed consent prior to registration on study.\n\nExclusion Criteria:\n\n* Patients who have severe or impairing psychiatric illness/social situations that would limit compliance with study requirements are not eligible to enroll.\n* Patients with early stage/non metastatic breast cancer (Stages I-III) are not eligible to enroll.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}